The purpose of this study is to determine if AMG 570 could be a useful therapeutic agent in the current treatment landscape where subjects with systemic lupus erythematosus (SLE) have ongoing disease activity despite treatment with standard of care therapies.
To Learn More Contact
Reference Study ID Number: CA41705 www.roche.com/about_roche/roche_worldwide.htm
888-662-6728 (U.S. and Canada)
ClinicalTrials.gov identifier: NCT04221477